A Comparison of Budesonide/Formoterol Maintenance and Reliever Therapy Versus Conventional Best Practice in Asthma Management in Spain

References

• GEMA 2009. Spanish guideline on the management of asthma. Executive Committee GEMA 2009. J Invest Allergol Clin Immunol 2010; 20 (suppl 1):1–59.
   PubMedGoogle Scholar
• Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2010. Available from: http://www.ginasthma.org. Accessed date December 2010.
   Google Scholar
• Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O’Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE. American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: Asthma control and exacerbations. Standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180:59–99.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Reddel HK, Eriksson G, Peterson S, Ostlund O, Sears MR, Jenkins C, Humbert M, Buhl R, Harrison TW, Quirce S, O’Byrne PM. Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol 2010; 125:600–608.
   PubMed Web of Science ®Google Scholar
• Lee C, Corren J. Budesonide/formoterol in the treatment of asthma. Expert Rev Respir Med 2008; 2:551–564.
   PubMedGoogle Scholar
• O’Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, Ekström T, Bateman ED. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005; 171:129–136.
   PubMed Web of Science ®Google Scholar
• Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin 2004; 20:1403–1418.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Pizzichini E, Ställberg B, Romero S, Balanzat AM, Atienza T, Lier PA, Jorup C. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest 2006; 129:246–256.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Bantje TA, João Gomes M, Toumbis MG, Huber RM, Naya I, Eliraz A. Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma. Am J Respir Med 2003; 2:275–281.
   PubMedGoogle Scholar
• Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006; 368:744–753.
   PubMed Web of Science ®Google Scholar
• Kuna P, Peters MJ, Manjra AI, Jorup C, Naya IP, Martínez-Jimenez NE, Buhl R. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract 2007; 61:725–736.
   PubMed Web of Science ®Google Scholar
• Vogelmeier C, D’Urzo A, Pauwels R, Merino JM, Jaspal M, Boutet S, Naya I, Price D. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J 2005; 26:819–828.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med 2007; 101:2437–2446.
   PubMed Web of Science ®Google Scholar
• Sears MR, Radner F. Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials. Respir Med 2009; 103: 1960–1968.
   PubMed Web of Science ®Google Scholar
• Loh LC, Lim BK, Raman S, Vijayasingham P, Mohd Yusuf S. Budesonide/formoterol combination therapy as both maintenance and reliever medication in moderate-to-severe asthma: a real-life effectiveness study of Malaysian patients. Med J Malaysia 2008; 63:188–192.
   PubMedGoogle Scholar
• Demoly P, Louis R, Søes-Petersen U, Naya I, Carlsheimer A, Worth H, Almeida J, Sears MR. Budesonide/formoterol maintenance and reliever therapy versus conventional best practice. Respir Med 2009; 103:1623–1632.
   PubMed Web of Science ®Google Scholar
• Sears MR, Boulet LP, Laviolette M, Fitzgerald JM, Bai TR, Kaplan A, Smiljanic-Georgijev N, Lee JS. Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma. Eur Respir J 2008; 31:982–989.
   PubMed Web of Science ®Google Scholar
• Louis R, Joos G, Michils A, Vandenhoven G. A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management. Int J Clin Pract 2009; 63:1479–1488.
   PubMed Web of Science ®Google Scholar
• Steurer-Stey C, Courteheuse C, Taegtmeyer AB, Leuppi JD. “Real-life”-data on asthma control using budesonide/formoterol for both maintenance and relief: the Swiss experience. Praxis (Bern 1994) 2009; 98:1335–1342.
   PubMedGoogle Scholar
• Juniper EF, Svensson K, Mörk AC, Ståhl E. Measurement properties and interpretation of three shortened versions of the Asthma Control Questionnaire. Respir Med 2005; 99:553–558.
   PubMed Web of Science ®Google Scholar
• Consejo General de Colegios de Farmacéuticos. Catálogo de Medicamentos. 2010. Madrid, Spain: Available at: http://www.portalfarma.com
   Google Scholar
• Oblikue Consulting Base de datos sanitarios e-salud. Disponible en: Available at: http://www.oblikue.com/bddcostes/. Accesed date: April 2009
   Google Scholar
• Juniper EF, Bousquet J, Abetz L, Bateman ED, Committee. GOAL. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir Med 2006; 100:616–621.
   PubMed Web of Science ®Google Scholar
• Edwards SJ, von Maltzahn R, Naya IP, Harrison T. Budesonide/formoterol for maintenance and reliever therapy of asthma: A meta-analysis of randomised controlled trials. Int J Clin Pract 2010; 64:619–627.
   PubMed Web of Science ®Google Scholar
• Aubier M, Buhl R, Ekström T, Ostinelli J, van Schayck CP, Selroos O, Haughney J. Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy. Eur Respir J 2010; 36(3):524–30.
   PubMed Web of Science ®Google Scholar
• Price D, Wirén A, Kuna P. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy. Allergy 2007; 62:1189–1198.
   PubMed Web of Science ®Google Scholar
• Johansson G, Andreasson EB, Larsson PE, Vogelmeier CF. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma. Pharmacoeconomics 2006; 24:695–708.
   PubMed Web of Science ®Google Scholar
• Miller E, FitzGerald JM. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies – A Canadian economic evaluation. Can J Clin Pharmacol 2008; 1515:e165–e176.
   PubMedGoogle Scholar
• Tamminen K, Laine J, Soini E, Martikainen J, Kankaanranta H. Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland. Curr Med Res Opin 2008; 24:3453–3461.
   PubMed Web of Science ®Google Scholar
• Cisneros C, Quiralte J, Capel M, Casado MA, Mellstrom C. Análisis coste-efectividad de budesonida/formoterol en el tratamiento de mantenimiento y a demanda (Symbicort SMART®) frente a salmeterol/fluticasona más terbutalina, en el tratamiento del asma persistente en España. Pharmacoeconomics Spanish Research Articles 2010; 7:163–170.
   Google Scholar
• Foresi A, Morelli MC, Catena E. Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. On behalf of the Italian Study Group. Chest 2000; 117:440–446.
   Google Scholar
• Oborne J, Mortimer K, Hubbard RB, Tattersfield AE, Harrison TW. Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: A randomized, double-blind, placebo-controlled, parallel-group clinical trial. Am J Respir Crit Care Med 2009; 180:598–602.
   PubMed Web of Science ®Google Scholar
• Toogood JH, Baskerville JC, Jennings B, Lefcoe NM, Johansson SA. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol 1982; 70:288–298.
   PubMed Web of Science ®Google Scholar
• Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: The INSPIRE study. BMC Pulm Med 2006; 6:13.
   PubMedGoogle Scholar